Clinical characteristics and factors associated with triple therapy use in newly diagnosed patients with COPD

Abstract There is limited information about the initiation of triple therapy (TT) in patients with chronic obstructive pulmonary disease (COPD) in primary care. This was an observational, population-based study in patients identified from a primary care electronic medical records database in Catalon...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Mònica Monteagudo, Miriam Barrecheguren, Iryna Solntseva, Nafeesa Dhalwani, Alison Booth, Alexa Nuñez, Dimitra Lambrelli, Marc Miravitlles
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Acceso en línea:https://doaj.org/article/53f3eceade6c4e54a4020da3b4fd6f5a
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:53f3eceade6c4e54a4020da3b4fd6f5a
record_format dspace
spelling oai:doaj.org-article:53f3eceade6c4e54a4020da3b4fd6f5a2021-12-02T16:36:11ZClinical characteristics and factors associated with triple therapy use in newly diagnosed patients with COPD10.1038/s41533-021-00227-x2055-1010https://doaj.org/article/53f3eceade6c4e54a4020da3b4fd6f5a2021-03-01T00:00:00Zhttps://doi.org/10.1038/s41533-021-00227-xhttps://doaj.org/toc/2055-1010Abstract There is limited information about the initiation of triple therapy (TT) in patients with chronic obstructive pulmonary disease (COPD) in primary care. This was an observational, population-based study in patients identified from a primary care electronic medical records database in Catalonia from 2011 to 2015 aimed to identify the use of TT in patients with newly diagnosed COPD. A total of 69,668 newly diagnosed patients were identified of whom 11,524 (16.5%) initiated TT, of whom 8626 initiated TT at or immediately after COPD diagnosis. Among them, 72.3% were GOLD A/B, 14.6% were frequent exacerbators, and 7.1% had asthma–COPD overlap (ACO). Variables associated with TT initiation were: male sex, older age, previous exacerbations, ACO, a previous treatment regimen containing an inhaled corticosteroid, previous pneumonia, and history of lung cancer. A significant number of COPD patients in Primary Care initiated TT shortly after or even before an established COPD diagnosis.Mònica MonteagudoMiriam BarrechegurenIryna SolntsevaNafeesa DhalwaniAlison BoothAlexa NuñezDimitra LambrelliMarc MiravitllesNature PortfolioarticleDiseases of the respiratory systemRC705-779ENnpj Primary Care Respiratory Medicine, Vol 31, Iss 1, Pp 1-7 (2021)
institution DOAJ
collection DOAJ
language EN
topic Diseases of the respiratory system
RC705-779
spellingShingle Diseases of the respiratory system
RC705-779
Mònica Monteagudo
Miriam Barrecheguren
Iryna Solntseva
Nafeesa Dhalwani
Alison Booth
Alexa Nuñez
Dimitra Lambrelli
Marc Miravitlles
Clinical characteristics and factors associated with triple therapy use in newly diagnosed patients with COPD
description Abstract There is limited information about the initiation of triple therapy (TT) in patients with chronic obstructive pulmonary disease (COPD) in primary care. This was an observational, population-based study in patients identified from a primary care electronic medical records database in Catalonia from 2011 to 2015 aimed to identify the use of TT in patients with newly diagnosed COPD. A total of 69,668 newly diagnosed patients were identified of whom 11,524 (16.5%) initiated TT, of whom 8626 initiated TT at or immediately after COPD diagnosis. Among them, 72.3% were GOLD A/B, 14.6% were frequent exacerbators, and 7.1% had asthma–COPD overlap (ACO). Variables associated with TT initiation were: male sex, older age, previous exacerbations, ACO, a previous treatment regimen containing an inhaled corticosteroid, previous pneumonia, and history of lung cancer. A significant number of COPD patients in Primary Care initiated TT shortly after or even before an established COPD diagnosis.
format article
author Mònica Monteagudo
Miriam Barrecheguren
Iryna Solntseva
Nafeesa Dhalwani
Alison Booth
Alexa Nuñez
Dimitra Lambrelli
Marc Miravitlles
author_facet Mònica Monteagudo
Miriam Barrecheguren
Iryna Solntseva
Nafeesa Dhalwani
Alison Booth
Alexa Nuñez
Dimitra Lambrelli
Marc Miravitlles
author_sort Mònica Monteagudo
title Clinical characteristics and factors associated with triple therapy use in newly diagnosed patients with COPD
title_short Clinical characteristics and factors associated with triple therapy use in newly diagnosed patients with COPD
title_full Clinical characteristics and factors associated with triple therapy use in newly diagnosed patients with COPD
title_fullStr Clinical characteristics and factors associated with triple therapy use in newly diagnosed patients with COPD
title_full_unstemmed Clinical characteristics and factors associated with triple therapy use in newly diagnosed patients with COPD
title_sort clinical characteristics and factors associated with triple therapy use in newly diagnosed patients with copd
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/53f3eceade6c4e54a4020da3b4fd6f5a
work_keys_str_mv AT monicamonteagudo clinicalcharacteristicsandfactorsassociatedwithtripletherapyuseinnewlydiagnosedpatientswithcopd
AT miriambarrecheguren clinicalcharacteristicsandfactorsassociatedwithtripletherapyuseinnewlydiagnosedpatientswithcopd
AT irynasolntseva clinicalcharacteristicsandfactorsassociatedwithtripletherapyuseinnewlydiagnosedpatientswithcopd
AT nafeesadhalwani clinicalcharacteristicsandfactorsassociatedwithtripletherapyuseinnewlydiagnosedpatientswithcopd
AT alisonbooth clinicalcharacteristicsandfactorsassociatedwithtripletherapyuseinnewlydiagnosedpatientswithcopd
AT alexanunez clinicalcharacteristicsandfactorsassociatedwithtripletherapyuseinnewlydiagnosedpatientswithcopd
AT dimitralambrelli clinicalcharacteristicsandfactorsassociatedwithtripletherapyuseinnewlydiagnosedpatientswithcopd
AT marcmiravitlles clinicalcharacteristicsandfactorsassociatedwithtripletherapyuseinnewlydiagnosedpatientswithcopd
_version_ 1718383633871405056